Talent Risk

Talent Risk · Employers · Pharma & healthcare

Novartis

Swiss pharmaceuticals companyPharma & healthcareHQ Switzerland≈76,000 staff

SignsStepping down: cuts in the last 180 days, nothing new in 90 · since 27th September 2026
Updated 21st November 202626 weeks
322
Jobs in announced cuts · 12 months
0.4%
Of its staff · 12 months
1st Jul 2026
Latest on record

Novartis is showing signs of job cuts.

Stepping down: cuts in the last 180 days, nothing new in 90. Latest, on 1st July: Novartis Pharmaceuticals Corporation filed a WARN notice for 322 employees at its East Hanover, New Jersey facility, effective October 2,…

This record counts only cuts announced publicly or filed as a formal notice; the everyday redundancies at any large employer are rarely announced and are not here.

How to read this page
  • The label (Cutting, Signs or Quiet) comes from one published rule applied to the sources listed: the company, formal notices and named outlets. The rule
  • The figures count each announcement once. Where a figure is left out, the record says why (one report only, offered not cut, same round).
  • Summary says what is happening and what would change the label; Full record lists every report, linked.

What’s happening, and where

No announced or filed job cuts in the last 90 days. The label rests on earlier signs, under Full record.

Which jobs Factory and production

Why, as stated Closing sites or units · Restructuring or new strategy · Cutting costs

Next This becomes Cutting if the company, a formal notice or two major outlets confirm cuts.

The last 12 months

DecJanFebMarAprMayJunJulAugSeptOctNov1st Jul 2026: Novartis Pharmaceuticals Corporation filed a WARN notice for 322 employees at its East Hanover, New Jersey facility, effective October 2, 2026.4th May 2026: Novartis announced closure of its Wehr facility in southern Baden, Germany, resulting in 220 job losses. The company is simultaneously investing in a new site in Saxony-Anhalt.25th Nov 2025: Novartis announced 550 job cuts at its largest Swiss manufacturing site in Stein by end of 2027, ceasing tablet and capsule production and sterile packaging there. Work to shift to lower-cost European facilities in Italy and Slovenia.550322220
CutsBuyouts, plans and signsHiringBigger mark = more jobs named

No cuts found this quarter. We found cuts in 2 of the three quarters before.

This label is our opinion, reached by applying one published rule to the sources listed. Novartis can correct the record at any time.

At a glance

LabelSigns since the week to 3rd Oct
Jobs in announced cuts, 12 months322 · 0.4% of about 76,000 staff
Latest on the record1st July 2026 · Cuts announced · 322 jobs
Jobs named in cutsFactory and production
Where the jobs areNew Jersey · Stein · US, Switzerland
Why, as statedClosing sites or units · Restructuring or new strategy · Cutting costs · Moving work abroad
Jobs we count322 of the 1,092 jobs reported, each round once; not counted: 220 in 1 figure: figure given by one report only. How we count
Normal for them?No cuts found this quarter. We found cuts in 2 of the three quarters before.
Sources, 12 months1 formal notice and 8 reports from 5 outlets, each linked below
Headquarters · sectorSwitzerland · Pharma & healthcare · NOVN
Which companyNovartis AG, the Swiss pharmaceuticals company. Not Sandoz, spun off in 2023.

Identifiers Wikidata Q507154 · LEI 5493007HIVTX6SY6XD66 · ISIN CH0012005267 · NVS on New York Stock Exchange · NOVN on Swiss Stock Exchange · About these

Filings under 42 other names count for Novartis

A formal notice counts here when it is filed by one of Novartis’s own legal entities, named exactly as below. Names two employers both claim are left out. How we match

Our list

Novartis Pharmaceuticals Corporation · Novartis Pharmaceuticals · Novartis Services · Novartis Gene Therapies

GLEIF register · source

Novartis Kapital AG · EVONILE PHARMA LIMITED · NOVARTIS INDIA LIMITED · NOVARTIS CAPITAL CORPORATION · Novartis Pharma GmbH · Alcon Ophthalmika GmbH · EBEWE Pharma Ges.m.b.H. Nfg.KG · Sandoz GmbH · NOVARTIS BIOVENTURES AG · Novartis International AG · SANDOZ INTERNATIONAL AG · NOVARTIS HEALTHCARE PRIVATE LIMITED · NOVARTIS INVESTMENT, LTD. · NOVARTIS SERVICES, INC. · NOVARTIS FINANCE SA · NOVARTIS PHARMA AG · SANDOZ PHARMA AG · NOVARTIS HOLDING AG · SANDOZ HOLDING AG · Novartis Investments S.à r.l.

Wikidata · source

Sandoz · Alcon · Chiron Corporation · Novartis (Singapore) · Novartis (France) · Novartis (Japan) · Novartis (United Kingdom) · Novartis Healthcare (India) · Novartis (Italy) · Novartis (Canada) · Novartis (Slovenia) · Novartis (Netherlands) · Novartis (Austria) · Novartis (China) · Novartis (Germany) · Novartis (Mexico) · Novartis · Novartis Baltics, SIA

What happened

Every event on the record, newest first. Each has its own page; open a row’s reports to see every source. How we decide

Nothing from Novartis, a formal notice or a named outlet about its workforce in the last 90 days.

Earlier on the record (3 events, up to a year)
  1. 1st Jul
    Novartis to cut 322 jobs

    Cuts announcedUSFormal notice

    Novartis Pharmaceuticals Corporation filed a WARN notice for 322 employees at its East Hanover, New Jersey facility, effective October 2, 2026.

    All 2 reports
    1. 1st Jul

      WARN notice (NJ) Official

      Novartis Pharmaceuticals Corporation filed a WARN notice for 322 employees at its East Hanover, New Jersey facility, effective October 2, 2026.

    2. 7th Jul

      Fierce Pharma Trade press

      Novartis announced layoffs of 322 employees at its U.S. headquarters in East Hanover, New Jersey, effective by October 2, 2026, according to a WARN Act filing.

    Its own page, with the facts →

    322jobs cut
  2. 4th May
    Novartis to cut 220 jobs

    Cuts announcedUSOne major outlet so far

    Novartis announced closure of its Wehr facility in southern Baden, Germany, resulting in 220 job losses. The company is simultaneously investing in a new site in Saxony-Anhalt.

    All 3 reports
    1. 4th May

      Fierce Pharma Trade press

      Novartis announced 60 additional job cuts at its U.S. headquarters in New Jersey, following 114 cuts announced in March as part of multiyear workforce reductions.

    2. 4th May

      Fierce Pharma Trade press

      Novartis announced additional cuts of 60 roles at its U.S. headquarters in East Hanover, New Jersey, following earlier cuts of 114 roles announced in March, as part of multiyear workforce reductions.

    3. 5th May

      Handelsblatt Major outlet

      Novartis announced closure of its Wehr facility in southern Baden, Germany, resulting in 220 job losses. The company is simultaneously investing in a new site in Saxony-Anhalt.

    Its own page, with the facts →

    220jobs, not yet confirmed
  3. 25th Nov 2025
    Novartis to cut 550 jobs

    Cuts announcedSteinReported by 3 major outlets

    Novartis announced 550 job cuts at its largest Swiss manufacturing site in Stein by end of 2027, ceasing tablet and capsule production and sterile packaging there. Work to shift to lower-cost European facilities in Italy and Slovenia.

    All 4 reports
    1. 25th Nov

      NZZ Major outlet

      Novartis announced 550 job cuts at its largest Swiss manufacturing site in Stein by end of 2027, ceasing tablet and capsule production and sterile packaging there. Work to shift to lower-cost European facilities in Italy and Slovenia.

    2. 25th Nov

      Handelsblatt Major outlet

      Novartis announced job cuts at Swiss locations while investing more than $100 million in those sites, prioritizing certain production.

    3. 25th Nov

      Tages-Anzeiger Major outlet

      Novartis announced 550 job cuts in Aargau, Switzerland, described as independent from US expansion plans.

    4. 26th Nov

      pharma.economictimes.indiatimes.com Trade press

      Novartis announced 550 job cuts in Switzerland as it transforms operations to focus on cell therapies and invests in modernizing production facilities.

    Its own page, with the facts →

    550jobs cut

Before this year: the formal record

Official documents only (US WARN notices and SEC filings) filed for Novartis since 2021. They are shown as filed, one row per document: a round notified at several sites appears once per site. They never change the label, which reads the last 90 days.

Formal documents by year
YearDocumentsJobs they state
2025235
2024129
20231103
20223500
20212586
Every document (9)
  1. 27th Mar 2025 WARN notice (CA) Official WARN notice filed for 1 employee in California, effective June 2025. Below the WARN Act threshold of 50 employees and does not constitute a reportable workforce event.
  2. 12th Mar 2025 WARN notice (CA) Official Novartis Pharmaceuticals Corporation filed a WARN notice for 34 employees in California, effective 2025-06-27.
  3. 5th Jul 2024 WARN notice (CA) Official Novartis Pharmaceuticals Corporation filed a WARN notice on 2024-07-05 for 29 employees affected by layoffs effective 2024-09-06 at a California location.
  4. 1st Aug 2023 WARN notice (NJ) Official Novartis Pharmaceuticals filed a WARN notice on 1 August 2023 for 103 employees at its Hanover, NJ facility, effective 24 November 2023.
  5. 1st Nov 2022 WARN notice (NJ) Official Novartis Services Inc filed a WARN notice for 4 employees at East Hanover, NJ, effective 28 January 2023.
  6. 1st Nov 2022 WARN notice (NJ) Official Novartis Pharmaceuticals filed a WARN notice for 221 employee layoffs at its East Hanover, NJ facility, effective 2023-01-28.
  7. 24th Oct 2022 WARN notice (IL) Official Novartis Gene Therapies filed WARN notice of 275 employee layoffs at Libertyville, Illinois facility.
  8. 1st Jun 2021 WARN notice (NJ) Official Novartis Pharmaceuticals Corporation filed a WARN notice for 186 employees at its East Hanover, NJ facility, effective 2021-09-10.
  9. 24th Mar 2021 WARN notice (CO) Official Novartis Gene Therapies filed a WARN notice for closure of its Boulder, Colorado facility, affecting 400 employees effective July 9, 2021.

Why, and how

4th May 2026 · Cuts announced

Why, as stated
Closing sites or unitsRestructuring or new strategy · reported
How
Sites closing

25th November 2025 · Cuts announced · 550 jobs

Why, as stated
Restructuring or new strategyCutting costsMoving work abroad
When
By December 2027
Where
Stein

“ist die Schweiz dafür nicht mehr wettbewerbsfähig. Man schaue sich nach alternativen Standorten in Europa um, wo die Lohnkosten und andere Aufwände geringer seien.”

In English: Switzerland is no longer competitive for this. The company is looking for alternative locations in Europe where labor costs and other expenses are lower.

NZZMajor outlet

Only what the sources say. If no report gives a reason, we don’t suggest one.

Named in its cuts
Factory and production
Countries named
USSwitzerland

In context

How the label has changed · 26 weeks

3rd OctCutting → Signs · Reported, not yet confirmed: trade press only
4th JulSigns → Cutting · Confirmed by the company or a formal notice (such as a US WARN notice)

Against its workforce

1 in 236of its staff (0.4%): 322 job cuts announced in 12 months, against a workforce of about 76,000.Each square is 1% of Novartis’s staff

Share of its sector’s cuts

12%

of the 2,749 job cuts announced in 12 months by the employers we rate in pharma & healthcare.

Peers in pharma & healthcare

  1. GSK1.8%
  2. AstraZeneca0.7%
  3. Novartis0.4%
  4. Novo Nordisk0.4%
  5. Johnson & Johnson0.2%

Job cuts in 12 months as a share of each employer’s workforce.

Use this record RSS · JSON · Embed · Ask an AI ·
Put Novartis’s label on your site

Two lines show the label and the latest cut, and update themselves. No cookies. About the badge

<div data-talentrisk="novartis"></div>
<script async src="https://talentrisk.com/embed.js"></script>

Right of reply

Novartis can reply or correct this record at any time.

Correct the record →

This label is our opinion, reached by applying one published rule to the sources listed.